MedTrace Logo

Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid Status

NCT03407287 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2021-04-12

No results posted yet for this study

Summary

The aim of this study is to determine the effects of fluid alternations, hemodynamic changes, mechanical ventilation, pharmacologic agents, positional changes, and comorbidities on the Peripheral Intravenous waveform Analysis (PIVA) signal.

Conditions

  • Systemic Inflammatory Response Syndrome
  • Distributive Shock
  • Hypotension and Shock
  • Decompensated Congestive Heart Failure
  • Atrial Fibrillation
  • High Risk Non-cardiac Surgery

Interventions

PROCEDURE

Peripheral Intravenous Analysis (PIVA)

Non-invasive measurement of peripheral venous waveform analysis (PIVA) obtained by connecting a standard transducer (AD Instruments, Colorado Springs, Co) to a universal adaptor or stopcock on a peripheral IV

PROCEDURE

Standard of care invasive vascular monitoring

Standard of care invasive monitoring in the intensive care settings with central venous catheters, pulmonary artery catheters, or trans-esophageal echocardiography for determining volume status.

PROCEDURE

Standard noninvasive vascular monitoring

Standard noninvasive vascular monitoring of blood pressure, pulse rate, pulse oximetry and respiratory rate.

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Kelly L. Kohorst, MD · Vanderbilt University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-08
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03407287 on ClinicalTrials.gov